Drug Information

Drug General Information
Drug ID
D04VSM
Former ID
DCL000297
Drug Name
CS-8958
Synonyms
Inavir; Laninamivir octanoate; R-118958
Drug Type
Small molecular drug
Indication Influenza virus [ICD10:J11.1] Phase 3 [522510]
Company
Biota
Structure
Download
2D MOL

3D MOL
Formula
C21H36N4O8
Canonical SMILES
CCCCCCCC(=O)OCC(C(C1C(C(C=C(O1)C(=O)O)N=C(N)N)NC(=O)C)O<br />C)O
InChI
1S/C21H36N4O8/c1-4-5-6-7-8-9-16(28)32-11-14(27)18(31-3)19-17(24-12(2)26)13(25-21(22)23)10-15(33-19)20(29)30/h10,13-14,17-19,27H,4-9,11H2,1-3H3,(H,24,26)(H,29,30)(H4,22,23,25)/t13-,14+,17+,18+,19+/m0/s1
InChIKey
UKTIJASCFRNWCB-RMIBSVFLSA-N
PubChem Compound ID
9847629
PubChem Substance ID
24741761, 44945695, 80150645, 99431572, 103614477, 142561135, 163642005, 198960282, 236253927, 246454553
Target and Pathway
Target(s) Neuraminidase Target Info Inhibitor [536970]
KEGG Pathway Other glycan degradation
References
Ref 522510ClinicalTrials.gov (NCT00803595) A Multinational Phase III Study of CS-8958 (MARVEL). U.S. National Institutes of Health.
Ref 536970Developing new antiviral agents for influenza treatment: what does the future hold? Clin Infect Dis. 2009 Jan 1;48 Suppl 1:S3-13.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.